Discover how innovative physical therapy, smart medications, nutrition strategies and mind-body techniques are transforming ...
The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.
It is a nothingness many people with chronic pain are plunged into when their symptoms defy simple explanation. As a physician and a scientist, I don’t believe in such diagnostic nihilism. Maybe ...
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...
A novel analysis of more than 375 published studies concluded that the association between chronic pain and rates of ...
5d
Clinical Trials Arena on MSNTris Pharma eyes approval after pain drug triumphs in second Phase III trialThe company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
According to joint experts, the best pillows for shoulder pain depend on sleep style, loft, fill and more. See our top 9 ...
Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...
Topline results were announced from a phase 3 trial evaluating cebranopadol for the treatment of moderate to severe acute pain in patients following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results